PIoglitazone for PrEvention of Restenosis in Diabetic Patients

NCT00376870 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Coronary Atherosclerosis
Coronary Restenosis
Diabetes

Interventions

DRUG: Pioglitazone
DRUG: Placebo

Sponsor

University of Rome Tor Vergata